Zuche Pharmaceuticals Private Limited, a active private limited company, was established on 20 July 2010 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U52100DL2010PTC206054. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.24 M.
It upholds a compliant status. Employing 38 professional, Its leadership includes Umesh Kumar Singh (Director), Tarun Bharal (Director). Past directors included Umesh Kumar Singh, Jagmeet Sapra Singh. It holds ₹4.90 Cr open charges and ₹6.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 602-D/19/4, Navkar Parkview Apartment Flat No-8, Ward No.-3 Mehrauli, Delhi, Delhi, 110030.
U52100DL2010PTC206054
206054
20 July 2010
₹0.50 M
₹0.24 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Zuche Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Umesh Kumar Singh | Director | 23 Jul 2021 | Current |
| Tarun Bharal | Director | 20 Jul 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Jun 2019 | Past |
| Pramod Abcsdd | Director | 23 May 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Zuche Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.51% increase. The company also saw a substantial improvement in profitability, with a 38.1% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Zuche Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹49,000,000.00
₹60,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jul 2023 | State Bank Of India | ₹4.90 Cr | Open |
| 24 Dec 2021 | Axis Bank Limited | ₹8.50 M | Satisfied |
| 29 Oct 2021 | Axis Bank Limited | ₹2.45 Cr | Satisfied |
| 26 Feb 2020 | State Bank Of India | ₹2.70 Cr | Satisfied |
Explore comprehensive loan charge details -
Zuche Pharmaceuticals has a workforce of 38 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Zuche Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zuche Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Zuche Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Zuche Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity A charge registered on 29 Oct 2021 via Charge ID 100518892 with Axis Bank Limited was fully satisfied on 19 Dec 2023. was completed.
Progress on A charge registered on 24 Dec 2021 via Charge ID 100523382 with Axis Bank Limited was fully satisfied on 17 Aug 2023. was documented.
A charge with State Bank Of India amounted to Rs. 49.00 M with Charge ID 100761866 was registered on 21 Jul 2023. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 8.50 M with Charge ID 100523382 was registered on 24 Dec 2021. was completed.
The CIN of Zuche Pharmaceuticals Private Limited is U52100DL2010PTC206054.
Zuche Pharmaceuticals Private Limited is headquartered at 602-D/19/4, Navkar Parkview Apartment Flat No-8, Ward No.-3 Mehrauli, Delhi, Delhi, 110030.
Zuche Pharmaceuticals Private Limited was incorporated on 20 July 2010.
The current directors of Zuche Pharmaceuticals Private Limited are
The primary industry of Zuche Pharmaceuticals Private Limited is Manufacturing.
Zuche Pharmaceuticals Private Limited is unlisted.
The authorized capital of Zuche Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.24 M.
The compliance status of Zuche Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX